Euclid Advisors’s Monsanto Co MON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-16,240
Closed -$1.68M 520
2016
Q2
$1.68M Sell
16,240
-1,640
-9% -$162K 0.07% 291
2016
Q1
$1.57M Buy
+17,880
New +$1.61M 0.06% 301
2015
Q3
Sell
-26,232
Closed -$2.8M 473
2015
Q2
$2.8M Buy
+26,232
New +$3.04M 0.06% 283
2014
Q4
Sell
-1,074,571
Closed -$121M 539
2014
Q3
$121M Buy
1,074,571
+123,520
+13% +$14.4M 0.87% 15
2014
Q2
$119M Sell
951,051
-281,710
-23% -$33M 0.83% 14
2014
Q1
$140M Buy
1,232,761
+331,080
+37% +$36.9M 1.06% 13
2013
Q4
$105M Sell
901,681
-28,390
-3% -$3.1M 0.87% 14
2013
Q3
$97.1M Buy
930,071
+175,129
+23% +$17.6M 0.98% 13
2013
Q2
$74.6M Buy
+754,942
New +$79.1M 0.94% 14

Other funds holding MON

Euclid Advisors's MON Position: Q3 2016 in Review

Euclid Advisors sold out of Monsanto Co (MON) in Q3 2016, closing a stake of 16,240 shares — an estimated $1.68M sold.

Euclid Advisors first reported a position in MON in Q2 2013 and held it in 9 quarters. The position peaked at $140M in Q1 2014. 958 funds tracked by Wall St. Rank hold MON as of Q3 2016.

  • Euclid Advisors reported no remaining Monsanto Co position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 16,240 Monsanto Co shares in Q3 2016, an estimated $1.68M.
  • Euclid Advisors first reported a position in Monsanto Co in Q2 2013 and held it in 9 quarters.
  • Euclid Advisors's Monsanto Co position peaked at $140M in Q1 2014.
  • 958 funds tracked by Wall St. Rank held Monsanto Co as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.